Concert Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Concert Pharmaceuticals Inc
CIK #0001367920
EDGAR Form CIK 2011 - 2026
10-K [0001367920]
10-Q [0001367920]
3 [0001367920]
4 [0001367920]
5 [0001367920]
8-K [0001367920]
SC 13D [0001367920]
SC 13G [0001367920]
Form 13D/13G Filer Form 13D/13G Subject Filed
Kynam Capital Management LP Concert Pharmaceuticals Inc [2023-02-10]
Kynam Capital Management LP Concert Pharmaceuticals Inc [2023-02-10]
Biotechnology Value Fund L P Concert Pharmaceuticals Inc [2021-11-15]
RA Capital Management LP Concert Pharmaceuticals Inc [2021-02-16]
BlackRock Inc Concert Pharmaceuticals Inc [2021-02-02]
Bank of America Corp /DE/ Concert Pharmaceuticals Inc [2020-02-14]
Dimensional Fund Advisors LP Concert Pharmaceuticals Inc [2020-02-12]
Arkin Moshe Concert Pharmaceuticals Inc [2020-02-06]
RTW Investments LP Concert Pharmaceuticals Inc [2019-03-25]
Biotechnology Value Fund L P Concert Pharmaceuticals Inc [2019-02-07]
View All
Form 3/4/5 Subject 2011 - 2026
Jaeger Wilfred E
Concert Pharmaceuticals Inc
HUTT Peter Barton
Hoeiland Jesper
Cassella James V
Becker Marc A
Aldrich Richard
van Heek Christi
Tung Roger D
Stuart Nancy
Munsie Jeffrey A
Auchincloss Thomas G
Barrett Ronald W
Lynch Ryan
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Wierenga Wendall
Fitzgerald Meghan
Herscha Lynette
Silverman Robert
Daws D Ryan
McGowan Pauline
Three Arch Management III LLC
Three Arch Management IV LLC
Schuhsler Helmut
Three Arch Associates IV LP
Three Arch Partners IV LP
Wan Mark A
Three Arch Associates III LP
Three Arch Partners III LP
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC
Delagardelle Jeani
Niedel James
Lathi Vijay K
Chambon Philippe O
New Leaf Venture Partners LLC
Hunt Ronald
Ratcliffe Liam
Skyline Venture Management IV LLC
Kaneko Yasunori
Skyline Venture Partners Qualified Purchaser Fund IV L P
Freund John Gordon
Brookside Capital Partners Fund LP
Brookside Capital Management LLC
Brookside Capital Investors L P
QVT Fund V LP
QVT Associates GP LLC
TVM Life Science Ventures VI GmbH & Co KG
TVM Life Science Ventures VI LP
Birner Hubert
Polack Axel
Goll Alexandra
Fischer Stefan
Adage Capital Partners GP LLC
Adage Capital Partners LP
Adage Capital Advisors LLC
Atchinson Robert
Gross Phillip
GlaxoSmithKline PLC
Flagship Ventures General Partner LLC
Flagship Ventures Fund 2004 L P
Afeyan Noubar
Kania Edwin
Greylock XII Limited Partnership
Greylock XII GP LLC
Greylock XII-A Limited Partnership
QVT Fund LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,250
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 40,432
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 22,410
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,250
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 49,500
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 110,000
Concert Pharmaceuticals Inc CNCE
Common Stock
2023-03-06 Tender 5,125
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 100,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 23,260
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 75,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 10,000
Concert Pharmaceuticals Inc CNCE
Stock Option (Right to Buy) · derivative
2023-03-06 Disposed to issuer 42,430
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com